Lattice to Showcase Advanced Edge AI Solutions at New-Tech 2025 Exhibition
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it will showcase its latest FPGA technology at the New-Tech 2025 Exhibition. Lattice technology demos will be featured in the Telsys Ltd. booth, showcasing industry-leading low power, small form factor FPGAs and application-specific solutions enabling advanced embedded vision, artificial intelligence, and sensor fusion capabilities.
Additionally, Lattice will deliver a technical presentation titled “Power-Efficient Robotics and Automation Fueled by Lattice FPGA Technology” about how advanced, power-optimized FPGAs can dramatically reduce power consumption for next-generation automation and robotics solutions for Industrial applications.
- Who: Lattice Semiconductor
- What / When:
- May 20 – 21: Lattice demo showcase (Telsys Ltd. Booth #67-68)
- May 21, 10:20 a.m.: “Power-Efficient Robotics and Automation Fueled by Lattice Semiconductor FPGA Technology” technical presentation
- Where: New-Tech 2025 Exhibition
- Event venue: EXPO Tel-Aviv Convention Center, Pavilion 1, Tel Aviv-Yafo, Israel
About Lattice Semiconductor
Lattice Semiconductor (NASDAQ: LSCC) is the low power programmable leader. We solve customer problems across the network, from the Edge to the Cloud, in the growing Communications, Computing, Industrial, Automotive, and Consumer markets. Our technology, long-standing relationships, and commitment to world-class support let our customers quickly and easily unleash their innovation to create a smart, secure, and connected world.
For more information about Lattice, please visit www.latticesemi.com. You can also follow us via LinkedIn, Twitter, Facebook, YouTube, WeChat, or Weibo.
Lattice Semiconductor Corporation, Lattice Semiconductor (& design), and specific product designations are either registered trademarks or trademarks of Lattice Semiconductor Corporation or its subsidiaries in the United States and/or other countries. The use of the word “partner” does not imply a legal partnership between Lattice and any other entity.
GENERAL NOTICE: Other product names used in this publication are for identification purposes only and may be trademarks of their respective holders.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250506423988/en/
Contacts
MEDIA CONTACT:
Sophia Hong
Lattice Semiconductor
503-268-8786
Sophia.Hong@latticesemi.com
INVESTOR CONTACT:
Rick Muscha
Lattice Semiconductor
408-826-6000
Rick.Muscha@latticesemi.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Amazon to Invest More Than $4 Billion to Launch Infrastructure Region in Chile7.5.2025 16:00:00 EEST | Press release
Amazon (NASDAQ: AMZN) today announced it plans to launch an Amazon Web Services (AWS) infrastructure Region in Chile by the end of 2026. The new AWS South America (Chile) Region will give developers, startups, entrepreneurs, and enterprises, as well as financial services, retail, education, government, and nonprofit organizations, greater choice for running their applications and serving end users from data centers located in Chile. As part of its long-term commitment, Amazon is planning to invest more than $4 billion in Chile to support the construction, connection, operation, and maintenance of its data centers in the country. For more information about AWS Global Infrastructure, visit aws.amazon.com/about-aws/global-infrastructure. “The AWS South America (Chile) Region will help serve the fast-growing demand for cloud services across Latin America and in Chile with secure, reliable, and efficient cloud infrastructure,” said Prasad Kalyanaraman, vice president of Infrastructure Servi
Crown Bioscience Achieves Green Lab Sustainability Certification7.5.2025 15:30:00 EEST | Press release
Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and a part of JSR Life Sciences and Japan-based JSR Corporation, today announced that its facility in Leiden, Netherlands, has achieved the highest level of certification in the My Green Lab Certification program. This ‘Green’ level certification is the gold standard in laboratory sustainability best practices. The My Green Lab Certification program, which is endorsed by the United Nations Race to Zero campaign, evaluated Crown Bioscience Netherlands across a range of sustainability metrics, including energy, water, waste, materials, recycling, and environmental engagement. After a thorough assessment, the lab earned a score of 81%—the highest level possible—demonstrating excellence and leadership in eco-friendly laboratory management. "We are thrilled to have our Netherlands site become the first My Green Lab certified location within Crown Bioscience," said Maria Radino, Vice President,
ELIQUENT Life Sciences Announces Strategic Acquisition of Azzur Consulting – Strengthening Full-Service Quality & Compliance Capabilities7.5.2025 15:30:00 EEST | Press release
ELIQUENT Life Sciences (ELIQUENT), a global regulatory, quality, and safety consulting firm, today announced the acquisition of Azzur Consulting, a leading quality and validation engineering firm. This strategic acquisition reinforces ELIQUENT’s position as a premier provider of end-to-end support for every stage of the product lifecycle. “Azzur Consulting has earned a reputation for hands-on, high-impact consulting in many of the life sciences industry’s most complex GxP environments. Their integration into ELIQUENT strengthens our platform and positions us to better serve clients with the tools, expertise, and operational capacity to move forward with speed and confidence,” said Tim Dietlin, Chief Executive Officer, ELIQUENT Life Sciences. With this acquisition, ELIQUENT gains deeper technical delivery capabilities that support life sciences companies across the product development lifecycle. Azzur Consulting’s network of seasoned quality, validation, and engineering professionals en
Microsoft Recommends Philips SpeechMike Premium Touch as the Successor to Nuance PowerMic7.5.2025 15:00:00 EEST | Press release
Speech Processing Solutions, global leader in professional dictation solutions under the Philips brand, today announced that the Philips SpeechMike Premium Touch has been officially recognized by Microsoft as the recommended successor to the soon-to-be-retired Nuance PowerMic series. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507643740/en/ The Philips SpeechMike Premium Touch. As the only microphone recommended by Microsoft for PowerMic replacement, the Philips SpeechMike Premium Touch delivers seamless, plug-and-play compatibility with many Nuance speech recognition solutions, including Dragon Medical One, Dragon Professional Anywhere, Dragon Legal Anywhere, and some versions of PowerScribe offering medical, legal and business professionals a superior alternative for uninterrupted documentation workflows. With an intuitive button layout mirroring the PowerMic, the Philips SpeechMike Premium Touch offers users a famil
Elegen Expands ENFINIA™ Platform with IVT Ready DNA to Streamline RNA Therapeutics Development7.5.2025 15:00:00 EEST | Press release
Elegen, the leader in next-generation cell-free DNA manufacturing, today announced the early access launch of ENFINIA™ IVT Ready DNA. An expansion of its ENFINIA platform, this new product is delivered ready-to-use with the requisite poly(A) tail already encoded. Full commercial availability is expected globally in early summer 2025. Built on Elegen’s proprietary cell-free technology, ENFINIA IVT Ready DNA delivers both standard and very complex double-stranded linear templates up to 5.5 kb that additionally include encoded poly(A) tails of 70–130 adenosines, with turnaround in as few as 10 business days. Compared to plasmid DNA, the process achieves low tail polydispersity and avoids the common pitfalls of plasmid-derived templates—including genomic DNA contamination, endotoxins from bacteria and time-consuming cloning, linearization and purification steps. Following successful pilots with customers across pharma, biotech and academia, the early access program is now open. To learn mo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom